The glioblastoma that originated from a low-grade astrocytoma is characterized by the methylation of the promoter of O6-Methylguanine-DNA-methyltransferase (MGMT) associated with TP53 mutations and partial LOH in chromosomes 10q, 13q, 19q, and 22q (Crespo et al., 2015). The gene discussed is MGMT; the disease is glioblastoma.